Skip to main content

Advertisement

SpringerLink
Log in

Advances in the management of gastroparesis

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

The treatment goals for patients with gastroparesis are to control symptoms; to correct fluid, electrolyte, and nutritional deficiencies; and to identify and treat the underlying cause of gastroparesis. For mild symptoms, dietary modifications and a low-dose antiemetic and/or prokinetic agent might provide satisfactory control of symptoms. Dietary treatments include decreasing the solid food component while increasing the liquid nutrient component of meals. Fat and fiber intake should be minimized. Metoclopramide, despite its potential for neurological side effects, remains a prokinetic treatment for symptomatic patients. In patients with diabetic gastroparesis, careful regulation of glycemic control may help to reduce symptoms. Medical management of patients with gastroparesis who do not respond to initial antiemetic or prokinetic therapy or who develop medication-related side effects involves the use of other prokinetic and antiemetic agents with different mechanisms of action. Combinations of prokinetic and antiemetic agents often are tried in patients with persistent symptoms. In some patients with persistent refractory symptoms and failure to maintain adequate fluid and/or nutritional intake, bypassing the stomach with jejunostomy feedings may be necessary. Gastric electrical stimulation is a treatment for refractory gastroparesis. Based on initial studies showing symptom benefit, especially in patients with diabetic gastroparesis, gastric electrical stimulation was granted humanitarian US Food and Drug Administration approval for the treatment of chronic, refractory nausea and vomiting secondary to idiopathic or diabetic gastroparesis. However, which patients are likely to respond, the optimal electrode position, and the optimal stimulation parameters remain areas that need to be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. He CL, Soffer EE, Ferris CD, et al.: Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121:427–434.

    Article  PubMed  CAS  Google Scholar 

  2. Sarnelli G, Caenepeel P, Geypens B, et al.: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia Am J Gastroenterol 2003, 98:783–788.

    Article  PubMed  Google Scholar 

  3. Lemann M, Dederding JP, Flourie B, et al.: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. Dig Dis Sci 1991, 36:1249–1254.

    Article  PubMed  CAS  Google Scholar 

  4. Parkman HP, Harris AD, Krevsky B, et al.: Gastroduodenal motility and dysmotility: update on techniques available for evaluation Am J Gastroenterol 1995, 90:869–892.

    PubMed  CAS  Google Scholar 

  5. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA: Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995, 36:93–96.

    PubMed  CAS  Google Scholar 

  6. Guo JP, Maurer AH, Fisher RS, Parkman HP: Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001, 46:24–29.

    Article  PubMed  CAS  Google Scholar 

  7. Tougas G, Eaker EY, Abell TL, et al.: Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000, 95:1456–1462.

    Article  PubMed  CAS  Google Scholar 

  8. Kuo B, McCallum RW, Koch KL, et al.: SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease [abstract]. Gastroenterology 2006, 130(4 Suppl 1):A434.

    Google Scholar 

  9. Bromer MQ, Kantor SN, Wagner DA, et al.: Simultaneous measurement of gastric emptying with a simple muffin meal using 13C-octanocate breath test and scintigraphy in normal subjects and patients with in dyspeptic symptoms. Dig Dis Sci 2002, 47:1657–1663.

    Article  PubMed  Google Scholar 

  10. Fontana RJ, Barnett JL: Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 1996, 91:2174–2178.

    PubMed  CAS  Google Scholar 

  11. Friedenberg F, Parkman HP: Management of delayed gastric emptying. Clin Gastroenterol Hepatol 2005, 3:642–646.

    Article  PubMed  Google Scholar 

  12. Rayner CK, Samsom M, Jones KL, Horowitz M: Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001, 24:371–381.

    Article  PubMed  CAS  Google Scholar 

  13. Fraser RJ, Horowitz M, Maddox AF, et al.: Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:675–680.

    Article  PubMed  CAS  Google Scholar 

  14. Brownlee M, Kroopf SS: Metoclopramide for gastroparesis diabeticorum. N Engl J Med 1974, 291:1257–1258.

    PubMed  CAS  Google Scholar 

  15. McCallum RW, Ricci DA, Rakatansky H, et al.: A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983, 6:463–467.

    Article  PubMed  CAS  Google Scholar 

  16. Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993, 153:1469–1475.

    Article  PubMed  CAS  Google Scholar 

  17. Miller LG, Jankovic J: Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989, 149:2486–2492.

    Article  PubMed  CAS  Google Scholar 

  18. Patterson D, Abell T, Rothstein R, et al.: A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999, 94:1230–1234.

    PubMed  CAS  Google Scholar 

  19. Watts GF, Armitage M, Sinclair J, Hill JD: Treatment of diabetic gastroparesis with oral domperidone. Diabet Med 1985, 2:491–492.

    Article  PubMed  CAS  Google Scholar 

  20. DiBaise JK, Quigley EM: Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis. J Clin Gastroenterol 1999, 28:131–134.

    Article  PubMed  CAS  Google Scholar 

  21. Maganti K, Onyemere K, Jones MP: Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003, 98:259–263.

    PubMed  CAS  Google Scholar 

  22. Erbas T, Varoglu E, Erbas B, et al.: Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 1993, 16:1511–1514.

    Article  PubMed  CAS  Google Scholar 

  23. Di Stefano M, Vos R, Janssens J, Tack JF: Effect of tegaserod, a 5-HT4 receptor partial agonist, on interdigestive and postprandial gastrointestinal motility in healthy volunteers [abstract]. Gastroenterology 2003, 124:A163.

    Article  Google Scholar 

  24. Degen L, Matzinger D, Merz M, et al.: Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects Aliment Pharmacol Ther 2001, 15:1745–1751.

    Article  PubMed  CAS  Google Scholar 

  25. Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms [abstract]. Gastroenterology 2003, 124:A54–A68.

    Article  Google Scholar 

  26. Bromer MQ, Friedenberg F, Miller LS, et al.: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005, 61:833–839.

    Article  PubMed  Google Scholar 

  27. Miller LS, Szych GA, Kantor SB, et al.: Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97:1653–1660.

    Article  PubMed  CAS  Google Scholar 

  28. Friedenberg F, Gollamudi S, Parkman HP: Review: the use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004, 2:165–175.

    Article  Google Scholar 

  29. Hotokezaka M, Adams RB, Miller AD, et al.: Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc 1996, 10:1008–1011.

    Article  PubMed  CAS  Google Scholar 

  30. Abell T, McCallum R, Hocking M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421–428.

    Article  PubMed  Google Scholar 

  31. Thumshirn M, Camilleri M, Cho MG, Zinsmeister AR: Modulation of gastric sensory and motor functions by nitrergic and alpha-2 adrenergic agents Gastroenterology 1999, 116:573–585.

    Article  PubMed  CAS  Google Scholar 

  32. Rosa-e-Silva L, Troncon LE, Oliveira RB, et al.: Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 1995, 9:179–183.

    Article  PubMed  CAS  Google Scholar 

  33. Tack J, Coulie B, Andrioli A, Janssens J: Influence of sumatriptan on gastric fundus tone and of the perception of gastric distension in man. Gut 2000, 46:468–473.

    Article  PubMed  CAS  Google Scholar 

  34. Sarnelli G, Vos R, Sifrim D, et al.: Influence of sildenafil on fasting and postprandial gastric tone in man [abstract]. Gastroenterology 2001, 120:A285–A286.

    Google Scholar 

  35. de Rosalmeida MC, Saraiva LD, da Graca JR, et al.: Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 2003, 48:2064–2068.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Section, Temple University School of Medicine, Parkinson Pavilion, 8th Floor, 3401 North Broad Street, Philadelphia, PA, 19140, USA

    Henry P. Parkman

Authors
  1. Frank K. Friedenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henry P. Parkman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry P. Parkman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedenberg, F.K., Parkman, H.P. Advances in the management of gastroparesis. Curr Treat Options Gastro 10, 283–293 (2007). https://doi.org/10.1007/s11938-007-0071-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-007-0071-6

Keywords

Search

Navigation